Lindbrook Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16
| Closed | -$56 | – | 2866 |
|
|
2024
Q2 | $56 | Buy |
+16
| New | +$56 | ﹤0.01% | 2729 |
|
|
2023
Q1 | – | Sell |
-588
| Closed | -$1.47K | – | 2846 |
|
|
2022
Q4 | $1.47K | Buy |
588
+519
| +752% | +$1.3K | ﹤0.01% | 2365 |
|
|
2022
Q3 | $0 | Sell |
69
-4
| -5% | – | ﹤0.01% | 2753 |
|
|
2022
Q2 | $0 | Buy |
+73
| New | – | ﹤0.01% | 2610 |
|
|
2020
Q3 | – | Sell |
-798
| Closed | -$12K | – | 1787 |
|
|
2020
Q2 | $12K | Buy |
+798
| New | +$12K | ﹤0.01% | 772 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$12K | – | 1763 |
|
|
2019
Q4 | $12K | Buy |
+500
| New | +$12K | ﹤0.01% | 877 |
|
|
2019
Q3 | – | Sell |
-2,000
| Closed | -$37K | – | 1471 |
|
|
2019
Q2 | $37K | Buy |
+2,000
| New | +$37K | 0.01% | 505 |
|